Jean-Christophe Francis Audonnet

This inventor holds 52 USPTO granted patents and 5 published patent applications, plus 9 CIPO patents and 28 EPO patents, primarily in Vaccine Development (CPC class A61K). Top assignees: Merial Limited, Boehringer Ingelheim Animal Health USA Inc., Asia-Pacific Special Nutrients Sdn. Bhd.. Active years: 1997-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Christophe Francis Audonnet. Retrieved from https://idiyas.com/inventor/jean-christophe-francis-audonnet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 52 (Patent Applications = 5)

% Patents Active = 94.2

CIPO Patents = 9 (Patent Applications = 3)

EPO Patents = 28 (Patent Applications = 19)

Average Co-Inventor Count = 3.2

ph-index = 10

Forward Citations = 425(Granted Patents)

Forward Citations (Not Self Cited) = 407(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Lyon, FR (2012)
Lyons, FR (1997 - 2020)

Company Filing History:

Boehringer Ingelheim Animal Health USA Inc.

patents

1 out of 1

Asia-Pacific Special Nutrients Sdn. Bhd.

patent

4. 1 out of 13

Chulalongkorn University

Rhone Merieux, Societe Anonyme

patent

8. 1 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

9. 1 out of 16,048

University of California

patents

10. 1 out of 37

University of Pretoria

patents

11. 2 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2020

Loading Chart...

Areas of Expertise:

Recombinant Vaccines

Polynucleotide Formulas

Adjuvant Strategies

FMDV Vaccines

Bluetongue Virus

DNA Vaccines

Vaccine Formulations

Feline Calicivirus

Canine Pathologies

Porcine Circovirus

Hendra Virus

West Nile Virus

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10632182 - Methods for freeze-drying and rehydrating biologics (2020-04-28),

2. 10487334 - Antibiotic-free plasmid (2019-11-26),

3. 10363300 - FMDV and E2 fusion proteins and uses thereof (2019-07-30),

4. 10350287 - Hendra virus recombinant compositions and uses thereof (2019-07-16),

5. 10125401 - High resolution melt genotyping of IBV, CSFV and NDV (2018-11-13),

6. 10076566 - Recombinant CDV compositions and uses thereof (2018-09-18),

7. 10010605 - FMDV recombinant vaccines and uses thereof (2018-07-03),

8. 9913891 - FMDV and E2 fusion proteins and uses thereof (2018-03-13),

9. 9669085 - Needle-free administration of PRRSV vaccines (2017-06-06),

10. 9345759 - Bluetongue virus recombinant vaccines and uses thereof (2016-05-24),

11. 9327137 - Recombinant CDV compositions and uses thereof (2016-05-03),

12. 8535682 - Recombinant vaccine against West Nile Virus (2013-09-17),

13. 8168200 - Vaccine against african horse sickness virus (2012-05-01),

14. 7998733 - Chimeric vectors (2011-08-16),

15. 7741437 - [object Object] (2010-06-22),

Title: Jean-Christophe Francis Audonnet - Innovative Inventor from Lyons, FR

Introduction: Jean-Christophe Francis Audonnet is a renowned inventor hailing from Lyons, France, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Jean-Christophe Francis Audonnet holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise and interests.

Career Highlights: Throughout his illustrious career, Jean-Christophe Francis Audonnet has been recognized for his pioneering work in developing cutting-edge solutions that have revolutionized industries and improved the lives of many.

Collaborations: Jean-Christophe Francis Audonnet has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge-sharing to drive progress and change.

Conclusion: Jean-Christophe Francis Audonnet's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology and beyond.

Profile summary based on public USPTO records.